CNTA logo

CNTA
Centessa Pharmaceuticals PLC - ADR

283
Mkt Cap
$3.76B
Volume
1.37M
52W High
$29.29
52W Low
$9.60
PE Ratio
-15.38
CNTA Fundamentals
Price
$27.54
Prev Close
$28.00
Open
$28.56
50D MA
$23.61
Beta
1.15
Avg. Volume
937,584.96
EPS (Annual)
-$2.06
P/B
12.48
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Guggenheim Raises Centessa Pharmaceuticals (NASDAQ:CNTA) Price Target to $43.00
Guggenheim upped their price objective on shares of Centessa Pharmaceuticals from $28.00 to $43.00 and gave the stock a "buy" rating in a research report on Tuesday...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve research firms that are presently...
MarketBeat·3d ago
News Placeholder
Candriam S.C.A. Buys New Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA
Candriam S.C.A. bought a new position in shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Free Report) during the second quarter, according to its most recent disclosure with the...
MarketBeat·3d ago
News Placeholder
Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Wells Fargo & Company upped their price objective on Centessa Pharmaceuticals from $30.00 to $35.00 and gave the company an "overweight" rating in a report on Thursday...
MarketBeat·6d ago
News Placeholder
Tia Bush Sells 40,000 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) CTO Tia Bush sold 40,000 shares of the stock in a transaction that occurred on Wednesday, November 12th. The shares were...
MarketBeat·6d ago
News Placeholder
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 12-Month High - Time to Buy?
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 52-Week High - What's Next...
MarketBeat·7d ago
News Placeholder
Why Centessa Pharmaceuticals Stock Crushed the Market Today
Key PointsIt's gearing up to take in a flood of fresh capital...
Nasdaq News: Markets·8d ago
News Placeholder
Centessa Pharmaceuticals (NASDAQ:CNTA) Announces Earnings Results
Centessa Pharmaceuticals (NASDAQ:CNTA - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.41) EPS for the quarter, missing analysts' consensus estimates of...
MarketBeat·12d ago
News Placeholder
Centessa Pharmaceuticals (NASDAQ:CNTA) Given New $30.00 Price Target at Wells Fargo & Company
Wells Fargo & Company reduced their target price on Centessa Pharmaceuticals from $31.00 to $30.00 and set an "overweight" rating on the stock in a report on Friday...
MarketBeat·12d ago
News Placeholder
Equities Analysts Offer Predictions for CNTA FY2029 Earnings
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Free Report) - Analysts at Leerink Partnrs dropped their FY2029 EPS estimates for Centessa Pharmaceuticals in a research report issued on...
MarketBeat·12d ago

Latest CNTA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.